Skip to content
Fiscal Receipts

Senate LDA lobbying filing

CENCORA, INC.

Registrant: CENCORA, INC. Year: 2026 Period: Second Quarter Type: Q2

View on lda.senate.gov ↗

Reported income

not reported

Reported expenses

$510.0K

Tracked program mentions4

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

  • Amphibious Combat Vehicle Family of Vehicles2025matched: “2025PE code cited directly

    Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)…

  • Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chainmatched 2+ title words

    Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription…

  • SPQ-9B Radar2026matched: “2026PE code cited directly

    Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)…

  • SSTD2213matched: “2213PE code cited directly

    Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act

Lobbying activities5

  • Health IssuesHCR

    Essential Medicines Strategic Stockpile Department of Defense Essential Medicines Strategic Stockpile Prescription Information Modernization Act (H.R.4132/S.2027) Mitigation of Drug Shortages Pharmaceutical supply chain resilience National Defense Authorization Act (NDAA - H.R.8800) Supply Chain Resiliency Most Favored Nation drug pricing proposals Direct to Consumer proposals CMS FY 2026 Medicares Part B Physician Fee Schedule Rule CMS ASP Certification Break Up Big Medicine Act (S. 3822) Management Services Organization (MSO) Role and value of community specialty physicians and MSOs Pandemic and All-Hazards Preparedness/Protecting Americans from All Hazards Preparedness Act (PAHPA) Protecting Patient Access to Cancer and Complex Therapies Act (H.R. 4299)

  • Medicare/MedicaidMMM

    Ensuring Community Access to Pharmacist Services Act (H.R. 3164)/ Main Street Pharmacy Access Act (H.R. 3164)/ Equitable Community Access to Pharmacist Services Act  (S.2426) Inflation Reduction Act implementation, including impact on Pharmacy & Physician Reimbursement Protecting Patient Access to Cancer and Complex Therapies Act 2025 (H.R 4299) Reimbursement policies impacting drug shortage Part B drug pricing changes Preventing and mitigating generic drug shortages CMS FY 2026 Medicares Part B Physician Fee Schedule CMS ASP Certification Medicare physician reimbursement CY2026 Medicare Physician Fee Schedule Rule Distributor bona fide service fees

  • PharmacyPHA

    Preventing and mitigating generic drug shortages Ensuring Seniors Access to Critical Medications Act/ Main Street Pharmacy Access Act (H.R. 3164)/Equitable Community Access to Pharmacist Services Act  (S.2426) Impacts to pharmacy Part D drug pricing in Inflation Reduction Act (IRA) Support for Fair Pharmacy Reimbursement

  • Taxation/Internal Revenue CodeTAX

    Global Intangible Low-taxed Income (GILTI) Territorial Economic Recovery Act (H.R. 363) The Medical Manufacturing, Economic Development, and Sustainability (MMEDS) Act (H.R. 3042) Restore Economic Vitality and Investment in the Virgin Islands Act (REVIVE VI Act) (858)

  • Trade (domestic/foreign)TRD

    Tariff proposed policies H.R.2213 - Medical Supply Chain Resiliency Act

Lobbyists5

  • COREY MCGEE
  • DARRELL ROGERS
  • FREDERICK ESSIS
  • SHELLY MUI-LIPNIK
  • VIVIENNE MITCHELL

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.